Dementia Alliance International (DAI) has launched a webinar series about dementia inclusive environments. The aim of the webinar series, curated by the DAI Environmental Design Special Interest Group, is to raise awareness and share global knowledge and skills in designing inclusive environments for people living with cognitive impairments and dementia. The first webinar was delivered…
Following the success of their 2025 Green Letter Days initiative, Dementia Adventure has launched Green Letter Days 2026. The 2026 Green Letter Days programme includes cycling (using adapted bikes, tricycles or tandem bikes), garden visits (to enjoy guided tours, seasonal blooms and landscaped spaces), cricket (visits to iconic venues including Lord’s), accessible tennis, boat trips,…
Dementia UK has launched a British Sign Language (BSL) service to support people who are deaf or hard of hearing to access Admiral Nurses. The service is in partnership with Sign Solutions and offers free online dementia support appointments with a BSL interpreter and an Admiral Nurse. This film explains more about Dementia UK’s BSL…
The Alzheimer’s Society has published a collection of reports entitled ‘The training gap: a hidden injustice in dementia care and how to fix it’. The reports focus on dementia training for social care staff across England, Wales, and Northern Ireland and were produced by Leeds Beckett University’s Centre for Dementia Research and IFF Research. The…
A Cochrane review has been published that analysed amyloid-targeting drugs for Alzheimer’s disease. The review looked at data from 17 clinical trials into seven anti-amyloid drugs, including lecanemab and donanemab. The trials involved more than 20,000 people in both successful and unsuccessful trials. The review’s conclusion is that the treatments in these trials had no…
Dementia UK has published a report entitled ‘A better death: fixing palliative and end of life care for dementia’. The report documents challenges around palliative and end of life care including: The improvements that are being recommended in this report include: Dr Hilda Hayo, Chief Admiral Nurse and Chief Executive of Dementia UK, says: “People…
The National Institute for Health and Care Excellence (NICE) is to look again at its decision not to fund Alzheimer’s disease drugs lecanemab and donanemab for use on the NHS. An appeal has found that NICE failed to properly account for the wider impact of the treatments, including on unpaid carers, when calculating the cost…
CrossSense has been announced as the winner of the £1m Longitude Prize on Dementia. CrossSense is a personalised AI-powered assistant, developed for smart glasses, that identifies everyday objects and guides people living with early-stage dementia through daily activities, with the aim of supporting them to live safely in their own homes for longer. Szczepan Orlins,…
SPIN-Dementia Network Plus has shared a film from their February 2026 event focusing on LGBTQIA+ and dementia. The event brought together SPIN-Dementia Network Plus, DETERMIND, Innovations in Dementia, and Together in Dementia Everyday (tide) to focus on brain health and the inequalities that LGBTQIA+ people face. The film features key moments from the event plus…
The Alzheimer’s Society has announced their Accelerator and Launchpad partners for 2026. The Accelerator and Launchpad programmes are designed to support innovative products and solutions that address challenges people with dementia experience. Accelerator partners have investment and business support for 12 months to help progress their innovations, whilst Launchpad partners have a 6-12 month support…